These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27821417)

  • 41. Angioscopy study from a large patient population comparing sirolimus-eluting stent with biodegradable versus durable polymer.
    Chen SL; Xu T; Zhang JJ; Ye F; Hu ZY; Tian NL; Zhang YJ; Kotani J; Zhang JX
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):420-8. PubMed ID: 21953920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study.
    Lee SY; Ahn JM; Mintz GS; Hur SH; Choi SY; Kim SW; Cho JM; Hong SJ; Kim JW; Hong YJ; Lee SG; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In-stent thin-cap fibroatheroma after drug-eluting stent implantation: ex-vivo evaluation of optical coherence tomography and intracoronary angioscopy.
    Fujii K; Hao H; Imanaka T; Kawano T; Takayama T; Hirayama A; Yamada T; Ishibashi-Ueda H; Hirota S; Masuyama T
    JACC Cardiovasc Interv; 2014 Apr; 7(4):446-7. PubMed ID: 24656539
    [No Abstract]   [Full Text] [Related]  

  • 44. Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation.
    Yoneda S; Abe S; Kanaya T; Oda K; Nishino S; Kageyama M; Taguchi I; Masawa N; Inoue T
    Coron Artery Dis; 2013 Aug; 24(5):368-73. PubMed ID: 23744617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OCT-verified peri-strut low-intensity areas and the extent of neointimal formation after 3 years following stent implantation.
    Choi JH; Granada JF; Kim JS; Song YB; Hahn JY; Choi SH; Tellez A; Milewski K; Hong MK; Jang Y; Lee SH; Gwon HC
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1156-60. PubMed ID: 23153916
    [No Abstract]   [Full Text] [Related]  

  • 46. Delayed onset of neointimal dissection within a drug-eluting stent deployed in the left main coronary artery.
    Nakamura T; Yasuda M; Ueno M; Kobuke K; Iwanaga Y; Miyazaki S
    Coron Artery Dis; 2019 May; 30(3):237-238. PubMed ID: 30694820
    [No Abstract]   [Full Text] [Related]  

  • 47. Optical coherence tomography to evaluate coronary stent implantation and complications.
    Hayat U; Thondapu V; Ul Haq MA; Foin N; Jang IK; Barlis P
    Coron Artery Dis; 2015 Aug; 26 Suppl 1():e55-68. PubMed ID: 26247272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
    Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries.
    Yoshida T; Sakata K; Nitta Y; Taguchi T; Kaku B; Katsuda S; Shimojima M; Gamou T; Nakahashi T; Konno T; Kawashiri MA; Yamagishi M; Hayashi K
    Heart Vessels; 2016 May; 31(5):635-42. PubMed ID: 25758470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unusually aggressive immature neo-intimal hyperplasia causing in-stent restenosis.
    McCutcheon K; Triantafyllis AS; Bennett J; Adriaenssens T
    Cardiovasc J Afr; 2017 Nov/Dec 23; 28(6):404-405. PubMed ID: 29019519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic neointimal pattern after drug-eluting stent implantation defined by optical coherence tomography.
    Yamamoto E; Xing L; Higuma T; Minami Y; Bryniarski K; Zanchin T; Wang Z; Aguirre AD; Lee H; Jang IK
    Coron Artery Dis; 2017 Nov; 28(7):557-563. PubMed ID: 28704243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thin-cap fibroatheroma and large calcification at the proximal stent edge correlate with a high proportion of uncovered stent struts in the chronic phase.
    Ueda T; Uemura S; Watanabe M; Dote Y; Goryo Y; Sugawara Y; Soeda T; Okayama S; Kawata H; Kawakami R; Okura H; Saito Y
    Coron Artery Dis; 2016 Aug; 27(5):376-84. PubMed ID: 27164267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation.
    Kim JS; Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):788-95. PubMed ID: 25051946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses.
    Di Vito L; Yoon JH; Kato K; Yonetsu T; Vergallo R; Costa M; Bezerra HG; Arbustini E; Narula J; Crea F; Prati F; Jang IK;
    Coron Artery Dis; 2014 Mar; 25(2):172-85. PubMed ID: 24356250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of attenuated-signal plaque observed by intravascular ultrasound on vessel response after drug-eluting stent implantation.
    Kitahara H; Waseda K; Sakamoto K; Yamada R; Huang CC; Nakatani D; Sakata K; Kawarada O; Yock PG; Matsuyama Y; Yokoi H; Nakamura M; Muramatsu T; Nanto S; Fitzgerald PJ; Honda Y
    Atherosclerosis; 2017 Apr; 259():68-74. PubMed ID: 28327450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
    Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neointimal tissue component assessed by tissue characterization with 40 MHz intravascular ultrasound imaging: comparison of drug-eluting stents and bare-metal stents.
    Tsujita K; Takaoka N; Kaikita K; Hokimoto S; Horio E; Sato K; Mizobe M; Nakayama N; Kojima S; Tayama S; Sugiyama S; Nakamura S; Ogawa H
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1068-74. PubMed ID: 23460385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple Mechanisms in 1 In-Stent Restenosis Assessed by Optical Coherence Tomography.
    Lu WD; Huang CW; Li YH; Chen JY
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2340-2341. PubMed ID: 29102578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.